Skip to content

Breast cancer

Effectiveness of a phone-based support program on self-care self-efficacy, psychological well-being, and quality of life among women newly diagnosed with breast cancer undergoing chemotherapy: a randomized controlled trial

Status
Active, not recruiting
Phases
Phase 1
Study type
Interventional
Source
TCTR
Registry ID
TCTR20230321010
Enrollment
94
Registered
2023-03-21
Start date
2023-04-07
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

A singled-blinded randomized controlled trial (RCT), pretest-posttest design technique was used to examine the effectiveness of the phone-based support program (PBSP) among women newly diagnosed with breast cancer undergoing chemotherapy. breast cancer self-care self-efficacy psychological well-being and quality of life

Interventions

A phone based support program (PBSP) refers to a program of nursing intervention for women with breast cancer who are undergoing chemotherapy developed by the researcher based on self-efficacy theory
Experimental Behavioral,Experimental Behavioral
the phone-based support program ,routine care

Sponsors

None listed

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: The participants will be recruited through the target population. The inclusion criteria will be:(1) at least 18 years of age, (2) newly diagnosed as breast cancer with non-metastatic or stage II or lower within the past 3-8 weeks, (3) treated with chemotherapy after surgery at the study sites, (4) be able to access the internet with a mobile phone (5) be contactable via the mobile phone for follow up; and (6) able to communicate Mandarin.

Exclusion criteria

Exclusion criteria: The exclusion criteria will be: (1) having a concurrent major physical illness, like any physical surgery except for the surgery treatment for breast cancer, injuries or illnesses with the potential for lifelong disability, advanced chronic illness, profound coma, permanent paralysis, or severe brain injury (2) having a chronic mental health problem as diagnoses by a psychiatrist, and (3) unable to complete all session of the implementation.

Design outcomes

Primary

MeasureTime frame
The Self-Care Self-Efficacy 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The Self-Care Self-Efficacy Scale

Secondary

MeasureTime frame
psychological well-being 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) The M.D. Anderson Symptom Inventory The Hospital Anxiety and Depression Scale (HADS),quality of life 3 time points of before the patient's intervention (T1, week 0), after completed the intervention week 3(T2), and at follow-up (T3, week7) European Organization for Research and Treatment of Cancer QOL

Countries

China

Contacts

Public ContactChen Xi

Jiangsu commission of Health

124512121@qq.com15949142113

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026